Exactly- now imagine all the good to great news the company has announced cumulative in the past 18 months, none of it is reflected in current day price. However big pharma and longs know what Leronlimab is really worth and it’s just a matter of the company not gaining new investors currently do to lack of media, no immediate anticipation date of game changing results such as interim results of Brazil and still about month half away from HIV BlA goal date. This has lead shorts to double and triple down on shorting until we get closer to the scoring.

I want to say we’re in the red zone now for the past year and sitting on the 1 inch line but there is a lightning delay so even though we’re on 1 inch line of approval everyone knows there gonna have to wait a bit for the game to resume and see their fav team score.